Pharmaceutical composition

Details Pharmaceutical composition Pharmaceutical composition

2007-03-20

2007-03-20

Flood, Michele (Department: 1655)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C514S892000, C424S055000, C424S078010, C424S078130

Reexamination Certificate

active

10716163

ABSTRACT:
A pharmaceutical composition comprising an analgesic or analgesic combination and a stool softener is disclosed. The analgesic is selected from morphine, meperidine, fentanyl, hydromorphone, oxymorphone, oxycodone, hydrocodone, methadone, propoxyphene, pentazocine, levorphanol, codeine, acetaminophen and combinations of these analgesics. The composition is formulated for oral administration as a liquid or solid dosage form for immediate, slow, delayed or sustained-release characteristics.

REFERENCES:
patent: 3980766 (1976-09-01), Shaw et al.
patent: 4181719 (1980-01-01), Margetts et al.
patent: 4366159 (1982-12-01), Magruder
patent: 4599342 (1986-07-01), LaHann
patent: 4762709 (1988-08-01), Sheumaker
patent: 4999200 (1991-03-01), Casillan
patent: 5232699 (1993-08-01), Colliopoulos
patent: 5516524 (1996-05-01), Kais et al.
patent: 5849240 (1998-12-01), Miller et al.
patent: 6284274 (2001-09-01), Merrill et al.
patent: 6375957 (2002-04-01), Kaiko et al.
patent: 2 281 204 (1995-03-01), None
patent: 2281205 (1995-03-01), None
Lazarus H et al., Hospice Journal, 1990, 6(4): 1-15. A multi-investigator clinical evaluation of oral controlled-release morphine (MS Contin [Registered Trademark] Tablets) administered to cancer patients.
Raeder J C et al., Anesthesia & Analgesia, 2001, 92(6): 1470-1472. Oral ibuprofen versus paracetamol plus codeine for analgesia after ambulatory surgery, Abstract.
Mullican, W S et al., Clinical Therapeutics, (Sep. 2001), 23(9): 1429-1445. Tramadol/acetaminophen combination tablets and codeine/acetaminophen combination capsules for the management of chronic pain: A comparative trial, Abstract.
Marketletter, (Jul. 7, 1997), US seniors surveyed on pain relief, pp N/A. An excerpt.
Maurer A H et al., J of Nuclear Medicine (May 1996), 37(5): 818-822. Opioid and opioid-like drug effects on whole-gut transit measured by scintigraphy, Abstract.
Rauck R L et al., Current Therapeutic Research-Clinical and Experimental, (Dec. 1994), 55(4): 1417-1431. Comparison of tramadol and acetaminophen in elderly patients, Abstract.
http://www.drugs.com/PDR/Senokot—Tablets.html (Jul. 25, 2004). Drugs.com (trademark). PDR Drug Information of SENOKOT-S(registered trademark) Tablets (standardized senna concentrate and docusate sodium) Natural Vegetable Laxative/Stool Softener Combination.
Persaud et al.Current Medical Research & Opinion(1985), 9(9):626-633. The relative bioavailibility of paracetarnol & codeine after oral administration of buclizine, paracetamol & codeine, with or without docusate, & or paracetamol alone in healthy volunteers.
Herndon, C. et al. Pharmacotherapy (Feb.-Mar. 2002), 22(2): 240-250. Management of opioid-induced gastrointestinal effects in patients receiving palliative care.
Adam, “A Treatment for the Acute Migraine Attack”;The Journal of International Medical Research; 1987; 15: pp. 71-75.
Persaud et al.; “The relative bioavailability of paracetamol and codeine after oral administration of a combination of buclizine, paracetamol and codeine, with or without docusate, and of paracetamol alone in healthy volunteers”;Current Medical Research and Opinions; vol. 9, No. 9, 1985; pp. 626-633.
Tylox® product information page; McNeil Pharmaceutical revised Jun. 1997.

Affiliated with

Also associated with

Rating

Pharmaceutical composition does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pharmaceutical composition, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical composition will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3743890